HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹202 Cr | ₹254 Cr | ₹233 Cr | ₹198 Cr | ₹114 Cr |
What is the latest Total Non-Current Liabilities ratio of HESTER BIOSCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹202 Cr |
Mar2024 | ₹254 Cr |
Mar2023 | ₹233 Cr |
Mar2022 | ₹198 Cr |
Mar2021 | ₹114 Cr |
How is Total Non-Current Liabilities of HESTER BIOSCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹202 Cr | -20.65 | |
Mar2024 | ₹254 Cr | 9.14 | |
Mar2023 | ₹233 Cr | 17.61 | |
Mar2022 | ₹198 Cr | 73.99 | |
Mar2021 | ₹114 Cr | - |
Compare Total Non-Current Liabilities of peers of HESTER BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HESTER BIOSCIENCES | ₹1,791.0 Cr | 0.5% | 7.9% | -12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
HESTER BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HESTER BIOSCIENCES | 0.5% |
7.9% |
-12.7% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses